HELICOBACTER PYLORI INFECTIONS
Clinical trials for HELICOBACTER PYLORI INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new HELICOBACTER PYLORI INFECTIONS trials appear
Sign up with your email to follow new studies for HELICOBACTER PYLORI INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter h. pylori treatment may work just as well as longer one
Disease control CompletedThis study looked at 508 adults with H. pylori infection to see if a 7-day triple therapy (vonoprazan, amoxicillin, tetracycline) works as well as a 14-day dual therapy (vonoprazan, amoxicillin). The goal was to compare how often the infection is cleared and how many side effects…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Sponsor: Yueyue Li • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Stomach bug treatment may boost blood platelets in ITP patients
Disease control CompletedThis study looked at whether treating Helicobacter pylori (a common stomach infection) with antibiotics can raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding and bruising. Researchers enrol…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Phase: NA • Sponsor: Al-Mustansiriyah University • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC
-
Stomach bug tied to belly fat and blood sugar issues?
Knowledge-focused CompletedThis study looked at health records from over 5,000 adults to see if having an H. pylori stomach infection is linked to metabolic syndrome—a cluster of conditions like high blood sugar, high blood pressure, and excess belly fat. Researchers compared people with and without the in…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Nanjing study reveals h. pylori resistance trends in thousands of patients
Knowledge-focused CompletedThis study looked at 7,227 patients in Nanjing to understand how resistant the H. pylori bacteria is to common antibiotics. The goal was to find out which antibiotics still work best and to help doctors choose the right treatment for each patient. No new treatments were tested; i…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
3000 patients studied to see Real-World success of h. pylori treatment
Knowledge-focused CompletedThis study looked back at medical records of 3000 people treated for H. pylori infection to see how often treatment actually works outside of controlled trials. Researchers collected data on which treatments were used and what factors, like antibiotic resistance or patient habits…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Sponsor: Run-hua Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Generic vonoprazan put to the test against Brand-Name voquezna
Knowledge-focused CompletedThis study compared a generic vonoprazan 20 mg tablet to the brand-name Voquezna in 28 healthy adults. Participants took a single dose of each under fasting conditions to see if the generic releases the same amount of drug into the bloodstream. The goal was to check bioequivalenc…
Matched conditions: HELICOBACTER PYLORI INFECTIONS
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC